CAPTRUST Financial Advisors’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
CAPTRUST Financial Advisors's CMPX Position: Q3 2026 in Review
CAPTRUST Financial Advisors reduced its Compass Therapeutics (CMPX) stake by 67% in Q3 2026, selling an estimated $45.1K and leaving 10,721 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3348.
CAPTRUST Financial Advisors first reported a position in CMPX in Q1 2025 and has held it in 7 quarters since. The position peaked at $115K in Q1 2026. 171 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.
- CAPTRUST Financial Advisors held 10,721 shares of Compass Therapeutics worth $11.2K as of Q3 2026.
- CAPTRUST Financial Advisors sold 21,888 Compass Therapeutics shares in Q3 2026, an estimated $45.1K.
- Compass Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3348 holding.
- CAPTRUST Financial Advisors first reported a position in Compass Therapeutics in Q1 2025 and has held it in 7 quarters since.
- CAPTRUST Financial Advisors's Compass Therapeutics position peaked at $115K in Q1 2026.
- 171 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.